4//SEC Filing
Furlow Brenda S. 4
Accession 0001437749-22-019665
CIK 0000842023other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:59 PM ET
Size
33.1 KB
Accession
0001437749-22-019665
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Furlow Brenda S.
SVP - General Counsel
Transactions
- Gift
Common Stock
2021-10-26−1,330→ 4,960 total - Tax Payment
Common Stock
2022-08-07$382.97/sh−969$371,098→ 5,960 total - Gift
Common Stock
2021-10-26−1,330→ 6,290 total - Gift
Common Stock
2021-10-26+1,330→ 1,330 total(indirect: By Trust) - Gift
Common Stock
2021-10-26+1,330→ 1,330 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2022-08-07+1,969→ 6,929 total - Exercise/Conversion
Restricted Stock Units
2022-08-07−1,969→ 0 total→ Common Stock (1,969 underlying)
Holdings
- 9,968
Stock Options (Right to Buy)
Exercise: $190.41Exp: 2026-08-07→ Common Stock (9,968 underlying) - 7,492
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (7,492 underlying) - 9,990
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (9,990 underlying) - 6,080
Stock Options (Right to Buy)
Exercise: $481.82Exp: 2028-08-06→ Common Stock (6,080 underlying) - 921
Stock Options (Right to Buy)
Exercise: $108.49Exp: 2022-08-07→ Common Stock (921 underlying) - 7,339
Stock Options (Right to Buy)
Exercise: $177.32Exp: 2025-08-08→ Common Stock (7,339 underlying) - 1,679
Restricted Stock Units
→ Common Stock (1,679 underlying) - 8,325
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying) - 10,997
Stock Options (Right to Buy)
Exercise: $372.44From: 2022-08-31Exp: 2028-03-01→ Common Stock (10,997 underlying) - 9,503
Stock Options (Right to Buy)
Exercise: $125.05Exp: 2024-08-09→ Common Stock (9,503 underlying) - 9,786
Stock Options (Right to Buy)
Exercise: $177.32Exp: 2025-08-08→ Common Stock (9,786 underlying) - 13,290
Stock Options (Right to Buy)
Exercise: $190.41Exp: 2026-08-07→ Common Stock (13,290 underlying) - 4,560
Stock Options (Right to Buy)
Exercise: $481.82Exp: 2028-08-06→ Common Stock (4,560 underlying) - 8,325
Stock Options (Right to Buy)
Exercise: $267.87Exp: 2027-08-05→ Common Stock (8,325 underlying) - 1,167
Restricted Stock Units
→ Common Stock (1,167 underlying)
Footnotes (10)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- [F10]Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
- [F2]Fully exercisable.
- [F3]On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
- [F4]Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
- [F5]Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- [F6]Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
- [F7]Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
- [F8]Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
- [F9]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001443851
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:59 PM ET
- Size
- 33.1 KB